|
Volumn 22, Issue 9, 2008, Pages 960-976
|
Assessing the issue of instability due to Michael adduct formation in novel chemical entities possessing a carbon-carbon double bond during early drug development - Applicability of common laboratory analytical protocols
|
Author keywords
Michael adduct; NCEs; , unsaturated carbonyl group
|
Indexed keywords
BIOCHEMISTRY;
CARBON;
CHEMICAL BONDS;
STRUCTURAL OPTIMIZATION;
UNSATURATED COMPOUNDS;
A-CARBON;
ADDUCT FORMATION;
ANALYTICAL PROTOCOLS;
CARBON-CARBON DOUBLE BONDS;
CARBONYL GROUPS;
CHEMICAL ENTITY;
DRUG DEVELOPMENT;
MICHAEL ADDUCTS;
NOVEL CHEMICAL ENTITY;
Α,Β-UNSATURATED CARBONYL GROUP;
NUCLEOPHILES;
CARBON;
DRF 2817;
DRF 6196;
DRF 6748;
DRF 6784;
DRF 6823;
DRF 6824;
DRF 6825;
DRF 6826;
DRF 6910;
DRF 6959;
DRF 6990;
DRF 6991;
DRF 8129;
DRF 8130;
DRF 8269;
DRF 8270;
DRF 8356;
GLUTATHIONE;
LINEZOLID;
NEW DRUG;
UNCLASSIFIED DRUG;
ARTICLE;
CHEMICAL BINDING;
CONTROLLED STUDY;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IN VITRO STUDY;
MASS SPECTROMETRY;
MICHAEL ADDITION;
MOLECULAR STABILITY;
ULTRAVIOLET SPECTROPHOTOMETRY;
|
EID: 53349142422
PISSN: 02693879
EISSN: 10990801
Source Type: Journal
DOI: 10.1002/bmc.1015 Document Type: Article |
Times cited : (1)
|
References (6)
|